End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.17 CNY | -2.15% | -6.33% | -28.15% |
07/05 | US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection | MT |
29/04 | Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.15% | 150.16Cr | |
+21.77% | 4.38TCr | |
+25.56% | 2.3TCr | |
+19.14% | 1.53TCr | |
+10.42% | 1.37TCr | |
+43.64% | 1.2TCr | |
-7.49% | 697.64Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.26% | 559.02Cr |
- Stock Market
- Equities
- 002675 Stock
- News Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
- Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug in Singapore